Analysts expect that HCP, Inc. (NYSE:HCP) will announce sales of $456.49 million for the current quarter, Zacks reports. Three analysts have provided estimates for HCP’s earnings, with estimates ranging from $442.20 million to $470.30 million. HCP reported sales of $492.17 million during the same quarter last year, which would suggest a negative year-over-year growth rate of 7.2%. The company is scheduled to report its next earnings report on Tuesday, May 1st.
According to Zacks, analysts expect that HCP will report full-year sales of $456.49 million for the current fiscal year, with estimates ranging from $1.74 billion to $1.83 billion. For the next year, analysts anticipate that the firm will post sales of $1.81 billion per share, with estimates ranging from $1.74 billion to $1.88 billion. Zacks’ sales calculations are a mean average based on a survey of analysts that that provide coverage for HCP.
HCP (NYSE:HCP) last issued its earnings results on Tuesday, February 13th. The real estate investment trust reported $0.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.47 by $0.01. The company had revenue of $443.30 million for the quarter, compared to the consensus estimate of $448.54 million. HCP had a return on equity of 6.99% and a net margin of 22.37%. The firm’s quarterly revenue was down 17.9% on a year-over-year basis. During the same quarter last year, the company earned $0.59 EPS.
Shares of HCP (NYSE HCP) traded up $0.51 on Friday, reaching $23.12. The company had a trading volume of 5,230,000 shares, compared to its average volume of 4,860,000. The company has a market cap of $10,850.00, a P/E ratio of 25.13, a PEG ratio of 4.14 and a beta of 0.29. HCP has a 52 week low of $21.48 and a 52 week high of $33.67. The company has a debt-to-equity ratio of 1.23, a current ratio of 0.31 and a quick ratio of 0.31.
The business also recently announced a quarterly dividend, which was paid on Friday, March 2nd. Stockholders of record on Thursday, February 15th were issued a $0.37 dividend. This represents a $1.48 dividend on an annualized basis and a dividend yield of 6.40%. The ex-dividend date was Wednesday, February 14th. HCP’s dividend payout ratio (DPR) is 160.87%.
In related news, insider Kendall K. Young bought 14,000 shares of the company’s stock in a transaction dated Wednesday, February 14th. The stock was purchased at an average price of $21.91 per share, for a total transaction of $306,740.00. Following the acquisition, the insider now owns 48,544 shares in the company, valued at $1,063,599.04. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. 0.22% of the stock is currently owned by insiders.
Institutional investors have recently made changes to their positions in the company. Vestpro Financial Partners Inc. dba CPF Texas purchased a new position in shares of HCP in the 4th quarter worth approximately $103,000. Fieldpoint Private Securities LLC purchased a new position in shares of HCP in the 3rd quarter worth approximately $147,000. Ellington Management Group LLC purchased a new position in shares of HCP in the 4th quarter worth approximately $232,000. Smith Shellnut Wilson LLC ADV purchased a new position in shares of HCP in the 3rd quarter worth approximately $234,000. Finally, Cullen Frost Bankers Inc. purchased a new position in shares of HCP in the 4th quarter worth approximately $244,000. Hedge funds and other institutional investors own 88.63% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “HCP, Inc. (HCP) Expected to Post Quarterly Sales of $456.49 Million” was originally published by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this piece of content on another website, it was copied illegally and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://sportsperspectives.com/2018/03/12/hcp-inc-hcp-expected-to-post-quarterly-sales-of-456-49-million.html.
HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.